Translational Stroke Research Using a Rabbit Embolic Stroke Model: A Correlative Analysis Hypothesis for Novel Therapy Development

Alteplase (tissue plasminogen activator, tPA) is currently the only FDA-approved treatment that can be given to acute ischemic stroke (AIS) patients if patients present within 3 h of an ischemic stroke. After 14 years of alteplase clinical research, evidence now suggests that the therapeutic treatme...

Descripción completa

Detalles Bibliográficos
Autor principal: Lapchak, Paul A.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881325/
https://www.ncbi.nlm.nih.gov/pubmed/20539748
http://dx.doi.org/10.1007/s12975-010-0018-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2881325/
https://www.ncbi.nlm.nih.gov/pubmed/20539748
http://dx.doi.org/10.1007/s12975-010-0018-4

Ejemplares similares